By: James Detar
ResMed RMD ) got a welcome improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 78 to 82, passing a benchmark along the way.
James Detar is a Copy Editor for Yahoo Finance and Investor's Business Daily. With a focus on financial news and stock market analysis, James provides readers with valuable insights into the performance and prospects of various companies. His articles cover a range of industries, including technology, retail, and energy.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Based on James Detar's article titles and coverage attributes, it is evident that he focuses predominantly on investment analysis and data citations in the context of stock market performance, retail companies, profit growth, and investing. Therefore, reaching out to him with pitches related to detailed financial analysis of company performances, insights into trends affecting retail businesses or specific companies' stock prospects could be well received.
Given his focus on investment analysis and citing data extensively in his articles, potential sources for outreach could include financial analysts providing in-depth market analyses or professionals with access to proprietary data supporting specific stock evaluations.
James does not appear to have a specific geographic focus but rather seems interested in analyzing and reporting on global market trends within the specified industries.
This information evolves through artificial intelligence and human feedback. Improve this profile .